搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
FierceBiotech
11 小时
FDA elevates Philips recall of hospital, home ventilator software
The FDA is getting the word out on a mandatory software update from Philips for its Trilogy line of portable life support ...
FierceBiotech
15 小时
Big pharma, biotech relations ‘won't necessarily be symbiotic’ in future AI landscape: S&P
Big Pharma is investing heavily in AI to slash development timelines and foster innovation. | Big Pharma is investing heavily ...
FierceBiotech
15 小时
Synchron’s brain-computer interface clears year-long safety study
Synchron has reported that its miniature brain-computer interface implant, threaded up through the blood vessels to help read the activity of the motor cortex, showed no major side effects in a ...
FierceBiotech
16 小时
Frazier Life Sciences adds $630M to 'evergreen' fund for small and mid-cap biotechs
Frazier Life Sciences has sourced a further $630 million for its fund focused on small and mid-cap biotechs. | Frazier Life ...
FierceBiotech
17 小时
Lundbeck taps Charles River for AI-enabled neuro drug discovery
Lundbeck has tapped Charles River Laboratories’ artificial intelligence capabilities to aid the discovery of neuroscience ...
FierceBiotech
17 小时
Nasal spray neutralizes army of respiratory diseases and protects mice from deadly influenza
The COVID-19 pandemic made the public acutely aware of how vulnerable their noses are. | The COVID-19 pandemic made us ...
FierceBiotech
18 小时
Zephyrm rides IPO updraft toward Hong Kong listing, seeking cash for phase 3 cell therapy ...
Zephyrm Bioscience is gusting toward the Hong Kong stock exchange, filing (PDF) for an IPO to bankroll phase 3 trials of its ...
FierceBiotech
19 小时
Triveni ropes in $115M series B less than a year after $92M fundraise
Triveni Bio has roped in $115 million in series B funds to advance preclinical antibody programs designed to treat ...
FierceBiotech
1 天
FDA clears Pi-Cardia's leaflet-splitting device for valve-in-valve TAVR procedures
Cardia’s ShortCut device, designed to open up previously implanted heart valves and clear a path for blood to flow into the ...
FierceBiotech
1 天
GE HealthCare's PET radiotracer for coronary artery disease nets FDA approval
GE HealthCare has secured the FDA’s approval for an injectable, radioactive imaging agent that gives clinicians a clearer ...
FierceBiotech
1 天
Cash-strapped Gritstone starts search for strategic alternatives as cancer vaccine data ...
Gritstone bio has brought in bankers to explore “potential value-maximizing strategies” after its phase 2 colorectal cancer ...
FierceBiotech
1 天
CAMP4, BioMarin ink research deal for genetic disease targets
BioMarin is adding kindling to the R&D fire, striking a match with CAMP4 Therapeutics for rights to select two targets ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈